Link preclinical	Year preclinical	acute/sustained preclinical	gnotobiotic preclinical	animal strain preclinical	animal sex preclinical	animal age value (days) preclinical	animal weight value (g) preclinical	species preclinical	mechanism_of_action preclinical	disease model preclinical	success measure preclinical	tested dose dependently preclinical	prophylactic / therapeutic preclinical	ribotype preclinical	c diff strain preclinical	c diff dose value preclinical	c diff dose units preclinical	c diff dose vegetative/spores preclinical	daily dosage preclinical	total dosage preclinical	dosage value preclinical	dosage units preclinical	dosage times per day preclinical	dosage duration preclinical	intervention preclinical	result preclinical	acute/sustained clinical	daily dosage clinical	total dosage clinical	dosage value clinical	dosage units clinical	dosage times per day clinical	dosage duration clinical	intervention class clinical	intervention clinical	dose dependence clinical	prophylactic / therapeutic clinical	Gender clinical	Age Groups clinical	Phases clinical	URL clinical	result clinical
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/77366	1978	acute	n/a	goldensyrian	n/a	42		hamster		challenge	deathfromenterocolitis	f	p		na	13	cfu		3		3	mg/ml		7	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	504		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26917573	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	vancomycin	0.4	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23689716	2013	acute	axenic	n/a	n/a	5		pig		challenge	cumulativemortality	t	t	27	uk6	1000000		spores	40	280	20	mg/kg	bid	7	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	acute	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25824219	2015	sustained	spf	c57bl/6	m	39		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	acute	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23324518	2013	sustained	n/a	goldensyrian	m	54	93	hamster	antibody	clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	3400000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	acute	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29483125	2018	sustained	n/a	goldensyrian	f	42	100	hamster		clindamycin+challenge	survival	f	t	12	630	100		spores	10	50	5	mg/kg	bid	5	vancomycin	0.4	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	acute	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	1	5	0.5	mg/kg	bid	5	vancomycin	0.625	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/19251726	2009	sustained	n/a	goldensyrian	m	42	99	hamster	methionyl-trnasynthetaseinhibitor	clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	16000000	cfu	vegetative	10	50	5	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	c57bl/6	n/a	56		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	10	mg/kg	bid	5	vancomycin	0.2	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	vancomycin	0.3125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.8	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	50	50	mg/kg	qd	1	vancomycin	0.5	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	100	50	mg/kg	qd	2	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	150	50	mg/kg	qd	3	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			50	250	50	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000									vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	vancomycin	0.3333333333333333	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	200	20	mg/kg	qd	10	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23217055	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		50	150	50	mg/kg	qd	3	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26832756	2016	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.3684210526315789	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29109161	2017	acute	n/a	c57bl/6	f	56		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	1000000	cfu	vegetative	20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	acute	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30482680	2018	sustained	n/a	c57bl/6j	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	500000		spores	50	250	50	mg/kg	qd	5	vancomycin	0.3888888888888889	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.8823529411764706	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	vancomycin	0.09090909090909091	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	vancomycin	0.7058823529411765	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.8181818181818182	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	acute	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18848941	2008	sustained	n/a	c57bl/6	f	63		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	10000	cfu		50	50	50	mg/kg	qd	1	vancomycin	0.4166666666666667	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	vancomycin	0.875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	vancomycin	0.5416666666666666	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	vancomycin	0.6875	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	acute	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/24514098	2014	sustained	n/a	goldensyrian	m		98	hamster	inhibitoroftypeiitopoisomeraseenzymes	clindamycin+challenge	cumulativemortality	t	t	53	b1	53		spores	12.5	50	6.25	mg/kg	bid	4	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/27527088	2016	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	f	t	12	630	680	cfu	spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	20	100	10	mg/kg	bid	5	vancomycin	0.1	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	sustained	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	5000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	0.16666666666666666	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	acute	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/30736358	2019	sustained	n/a	goldensyrian	m		100	hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	100		spores	20	60	20	mg/kg	qd	3	vancomycin	0.1	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			50	300	50	mg/kg	qd	6	vancomycin	0.3	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	acute	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/15388461	2004	sustained	n/a	goldensyrian	n/a		113	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.35714285714285715	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.7	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.9	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	vancomycin	0.25	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	vancomycin	0.125	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	vancomycin	0.375	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22203600	2012	acute	n/a	goldensyrian	f		85	hamster	selectivelyinhibitsthereplication-specificdnapolymeraseofclostridiumdifficile	clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	10000000	cfu	spores	100	300	50	mg/kg	bid	3	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.8333333333333334	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		100	500	50	mg/kg	bid	5	vancomycin	0.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33782498	2021	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	survival	t	t	428	va11	7500000	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.7	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		40	200	20	mg/kg	bid	5	vancomycin	0.55	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	1.0	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8939393939393939
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.6440677966101694
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	125		125	mg	qd		antibiotic	vancomycin	no	prophylactic	all	olderadult	phase4	https://ClinicalTrials.gov/show/NCT02951702	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8538205980066446
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6179401993355482
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8490566037735849
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6226415094339622
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.8212290502793296
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.5921787709497207
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.8357142857142857
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.6107142857142858
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8184931506849316
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.589041095890411
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8796296296296297
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6574074074074074
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.1875
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8636363636363636
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5454545454545454
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7045454545454546
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7419354838709677
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.86328125
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.7792792792792793
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8566775244299675
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.7452471482889734
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.6347826086956522
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.863013698630137
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.808
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8235294117647058
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.8059701492537313
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7570093457943925
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.696969696969697
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.6086956521739131
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.6666666666666666
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute	500	5000	125	mg	qid	10	antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	1.0
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							control	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	acute							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	vancomycin	0.6	sustained							antibiotic	vancomycin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33305657	2020	acute	n/a	c57bl/6	n/a	84		mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000		spores	1000	1000	10^3	spores	qd	1	ntcd-035	1.0	sustained	10000	70000	10000	spores	qd	7	probiotic	ntcd-035	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33305657	2020	acute	n/a	c57bl/6	n/a	84		mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000		spores	1000	1000	10^3	spores	qd	1	ntcd-035	1.0	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	ntcd-035	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/33305657	2020	acute	n/a	c57bl/6	n/a	84		mouse		neomycin+metronidazole+vancomycin+clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	1000		spores	1000	1000	10^3	spores	qd	1	ntcd-035	1.0	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	ntcd-035	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.4	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.3	1.5	0.3	mg/kg	qd	5	cadazolid	0.2	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	10	50	10	mg/kg	qd	5	cadazolid	0.4	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	100	500	100	mg/kg	qd	5	cadazolid	0.8	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	12.5	62.5	12.5	mg/kg	qd	5	cadazolid	0.4	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	25	125	25	mg/kg	qd	5	cadazolid	0.6	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	3	15	3	mg/kg	qd	5	cadazolid	0.2	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	30	150	30	mg/kg	qd	5	cadazolid	0.5	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	300	1500	300	mg/kg	qd	5	cadazolid	0.6	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	goldensyrian	m	58	111	hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	50	250	50	mg/kg	qd	5	cadazolid	0.4	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.4672897196261682	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9649122807017544	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	acute	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	1.0	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	0.2	1	0.1	mg/kg	bid	5	cadazolid	0.40186915887850466	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	2	10	1	mg/kg	bid	5	cadazolid	0.9210526315789473	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.8068965517241379
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01983683	0.6310344827586207
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.8377483443708609
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01987895	0.6556291390728477
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	acute	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9411764705882353
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	acute	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.9
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	acute	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.8421052631578947
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	sustained	500	5000	250	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7647058823529411
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	sustained	1000	10000	500	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.7
https://pubmed.ncbi.nlm.nih.gov/24277020	2014	sustained	n/a	c57bl/6	f	70		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu	spores	20	100	10	mg/kg	bid	5	cadazolid	0.8785046728971962	sustained	2000	20000	1000	mg	bid	10	antibiotic	cadazolid	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01222702	0.5555555555555556
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	acute	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.04	0.2	0.04	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		0.2	1	0.2	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		1	5	1	mg/kg	qd	5	fidaxomicin	0.3	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/33495229	2021	sustained	spf	goldensyrian	m	39		hamster		challenge+clindamycin	survival	t	t	87	vpi10463	1000000	cfu		5	25	5	mg/kg	qd	5	fidaxomicin	0.9	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.8	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000	cfu		20	100	20	mg/kg	qd	5	fidaxomicin	0.2	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.3	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	20	100	10	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	5	25	2.5	mg/kg	bid	5	fidaxomicin	0.9	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.3333333333333333	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.03	0.15	0.03	mg/kg	qd	5	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	30000		spores	0.3	1.5	0.3	mg/kg	qd	5	fidaxomicin	0.16666666666666666	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.2	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	2	10	1	mg/kg	bid	5	fidaxomicin	0.4	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	1	1	1	mg/kg	qd	1	fidaxomicin	0.0	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	200	16000	200	mg	qd	40	antibiotic	fidaxomicin	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	100	1000	50	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	200	2000	100	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	4000	200	mg	bid	10	antibiotic	fidaxomicin	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	acute	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/29439962	2018	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	27	2009155	40000		spores	3	15	3	mg/kg	qd	5	fidaxomicin	0.5	sustained	400	5600	200	mg	bid	5	antibiotic	fidaxomicin	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/26461425	2015	acute	n/a	c57bl/6	f	39		mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	p	27	uk6	10000000		spores	2000000	4000000	10^6	vegetativecells	bid	2	clostridiumdifficilecd37	0.8	sustained	10000	70000	10000	spores	qd	7	probiotic	clostridiumdifficilecd37	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/26461425	2015	acute	n/a	c57bl/6	f	39		mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	p	27	uk6	10000000		spores	2000000	4000000	10^6	vegetativecells	bid	2	clostridiumdifficilecd37	0.8	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	clostridiumdifficilecd37	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/26461425	2015	acute	n/a	c57bl/6	f	39		mouse		ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	p	27	uk6	10000000		spores	2000000	4000000	10^6	vegetativecells	bid	2	clostridiumdifficilecd37	0.8	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	clostridiumdifficilecd37	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	1	6	1	mg/kg	qd	6	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/33045352	2020	acute	n/a	c57bl/6	f	42		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	800000	cfu	spores	10	60	10	mg/kg	qd	6	metronidazole	0.6	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		50	500	50	mg/kg	qd	10	metronidazole	0.6666666666666666	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	acute	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/31849218	2020	sustained	n/a	c57/b6	f	49		mouse		cefoperazone+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	8600000	cfu		20	140	20	mg/kg	qd	7	metronidazole	0.5	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	100000			20	100	20	mg/kg	qd	5	metronidazole	0.8333333333333334	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		210	1050	210	mg/kg	qd	5	metronidazole	0.2	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	acute	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	1.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained	1500	15000	500	mg	tid	10	antibiotic	metronidazole	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00182429	0.2
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.725925925925926
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.8018867924528302
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	acute	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7132867132867133
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained	1500	15000	375	mg	qid	10	antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.7289719626168224
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained							control	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	acute							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22869573	2012	sustained	n/a	goldensyrian	n/a		90	hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	50000000	cfu		300	1500	150	mg/kg	bid	5	metronidazole	0.0	sustained							antibiotic	metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.8
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.6
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained	250	250	250	ml	qd	1	fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT02465463	0.75
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.847457627118644
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.9
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT03106844	0.9183673469387755
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	acute							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.7083333333333334
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.7027027027027027
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.75
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	acute							fmt	fmt-fd	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.7
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	acute							fmt	fmt-fd	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.95
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	0.5
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-fd	0.7	sustained							fmt	fmt-fd	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	1.0
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.8
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.6
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained	250	250	250	ml	qd	1	fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT02465463	0.75
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.847457627118644
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.9
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT03106844	0.9183673469387755
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	acute							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.7083333333333334
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.7027027027027027
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.75
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	acute							fmt	fmt-g10	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.7
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	acute							fmt	fmt-g10	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.95
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	0.5
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g10	0.55	sustained							fmt	fmt-g10	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	1.0
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.8
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.6
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained	250	250	250	ml	qd	1	fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT02465463	0.75
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.847457627118644
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.9
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT03106844	0.9183673469387755
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	acute							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.7083333333333334
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.7027027027027027
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.75
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	acute							fmt	fmt-g80	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.7
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	acute							fmt	fmt-g80	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.95
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	0.5
https://pubmed.ncbi.nlm.nih.gov/32501140	2020	acute	n/a	c57bl/6	f	46		mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	27	r20291	8000	cfu	vegetative							fmt-g80	0.6	sustained							fmt	fmt-g80	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	1.0
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	m3,antcdstrain	1.0	sustained	10000	70000	10000	spores	qd	7	probiotic	m3,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	m3,antcdstrain	1.0	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	m3,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	m3,antcdstrain	1.0	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	m3,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	m3,antcdstrain	0.9	sustained	10000	70000	10000	spores	qd	7	probiotic	m3,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	m3,antcdstrain	0.9	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	m3,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	m3,antcdstrain	0.9	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	m3,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	t7,antcdstrain	1.0	sustained	10000	70000	10000	spores	qd	7	probiotic	t7,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	t7,antcdstrain	1.0	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	t7,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	acute	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000		10^6	cfuofspores	qd	1	t7,antcdstrain	1.0	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	t7,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	t7,antcdstrain	0.8	sustained	10000	70000	10000	spores	qd	7	probiotic	t7,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	t7,antcdstrain	0.8	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	t7,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/23939887/	2013	sustained	n/a	goldensyrian	m	49		hamster		clindamycin+challenge	mortality	f	p	27	bi1	100	cfu	spores	1000000	1000000	10^6	cfuofspores	qd	1	t7,antcdstrain	0.8	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	t7,antcdstrain	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.8333333333333334	sustained							control	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.8333333333333334	sustained							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.8333333333333334	sustained							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.8333333333333334	acute							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	acute	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.8333333333333334	sustained							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.6666666666666666	sustained							control	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.7407407407407407
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.6666666666666666	sustained							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7215189873417721
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.6666666666666666	sustained							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.2631578947368421
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.6666666666666666	acute							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/26568840	2015	sustained	n/a	c57bl/6j	f	49	19	mouse		kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	200000	cfu		100	1000	50 vancomycin + 50 metronidazole	mg/kg	qd	10	vancomycin+metronidazole	0.6666666666666666	sustained							antibiotic	vancomycin+metronidazole	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02589847	0.30666666666666664
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	nitazoxanide	0.25	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/22585229	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	10000	cfu		20	100	20	mg/kg	qd	5	nitazoxanide	0.25	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	acute	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	nitazoxanide	0.625	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/23147742	2012	sustained	n/a	c57bl/6	m	56		mouse		vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge	cumulativemortality	f	t	87	vpi10463	50000			20	100	20	mg/kg	qd	5	nitazoxanide	0.625	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	nitazoxanide	1.0	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			30	180	30	mg/kg	qd	6	nitazoxanide	0.5	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			75	450	75	mg/kg	qd	6	nitazoxanide	1.0	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			150	900	150	mg/kg	qd	6	nitazoxanide	0.0	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			30	180	30	mg/kg	qd	6	nitazoxanide	0.0	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/10952564	2000	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	f	t		ttu614	100000			75	450	75	mg/kg	qd	6	nitazoxanide	0.0	sustained	1000		500	mg	bid		other	nitazoxanide	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00304356	1.0
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.8888888888888888	sustained	10000	70000	10000	spores	qd	7	probiotic	pcd130+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.8888888888888888	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	pcd130+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.8888888888888888	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	pcd130+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.5555555555555556	sustained	10000	70000	10000	spores	qd	7	probiotic	pcd130+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.5555555555555556	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	pcd130+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd130+027	0.5555555555555556	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	pcd130+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888	sustained	10000	70000	10000	spores	qd	7	probiotic	pcd182+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	pcd182+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	acute	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	pcd182+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888	sustained	10000	70000	10000	spores	qd	7	probiotic	pcd182+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888	sustained	10000000	70000000	10000000	spores	qd	7	probiotic	pcd182+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.9534883720930233
https://pubmed.ncbi.nlm.nih.gov/33202811	2020	sustained	n/a	goldensyrian	f		95	hamster		clindamycin+challenge	cumulativemortality	f	p	27	cd13-12	5000	cfu	spores	1000000	1000000	10^6	spores	qd	1	pcd182+027	0.8888888888888888	sustained	10000000	140000000	10000000	spores	qd	14	probiotic	pcd182+027	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01259726	0.8536585365853658
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	acute	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	sustained	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.9696969696969697	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	acute	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	sustained	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	acute	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	sustained	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	acute	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	sustained	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	20	100	10	mg/kg	bid	5	cb-183,315	0.7575757575757576	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	acute	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	sustained	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	4	20	2	mg/kg	bid	5	cb-183,315	0.5	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	acute	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	sustained	250	2500	125	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	acute	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/22802252	2012	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	t	t	12	atcc43596	20		spores	50	250	25	mg/kg	bid	5	cb-183,315	0.8125	sustained	500	5000	250	mg	bid	10	antibiotic	cb-183,315	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	250	2500	125	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	500	5000	250	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	250	2500	125	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	acute	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	250	2500	125	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.9242424242424242
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	500	5000	250	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8656716417910447
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	250	2500	125	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.7213114754098361
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	surotomycin	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01085591	0.8275862068965517
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.7896551724137931
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01597505	0.603448275862069
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	acute	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.8315789473684211
https://pubmed.ncbi.nlm.nih.gov/25993059	2015	sustained	n/a	goldensyrian	m			hamster		clindamycin+challenge	cumulativemortality	f	t	12	atcc43596	20		spores	0.5	2.5	0.5	mg/kg	qd	5	surotomycin	1.0	sustained	500	5000	250	mg	bid	10	antibiotic	surotomycin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01598311	0.631578947368421
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	swisswebster	n/a			mouse	antibody	toxinaintraperitoneally	survival	f	p	87	vpi10463	100	ngtoxina				100 to 250	ug			cda1	0.6666666666666666	sustained	10	10	10	mg/kg	qd	1	antibody	cda1	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7370689655172413
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores	50	200	50	mg/kg	qd	4	cda1	0.5476190476190477	sustained	10	10	10	mg/kg	qd	1	antibody	cda1	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7370689655172413
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores	50	200	50	mg/kg	qd	4	cda1	0.047619047619047616	sustained	10	10	10	mg/kg	qd	1	antibody	cda1	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7370689655172413
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	60	240	60	mg/kg	qd	4	cda1	0.5581395348837209	sustained	10	10	10	mg/kg	qd	1	antibody	cda1	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7370689655172413
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	60	240	60	mg/kg	qd	4	cda1	0.32558139534883723	sustained	10	10	10	mg/kg	qd	1	antibody	cda1	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.7370689655172413
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			10 to 50	mg/kg	qd	4	mdx1388	0.17647058823529413	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.8487179487179487
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			10 to 50	mg/kg	qd	4	mdx1388	0.17647058823529413	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.8238341968911918
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			10 to 50	mg/kg	qd	4	mdx1388	0.0	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.8487179487179487
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge	cumulativemortality	f	p	87	vpi10463	140	cfu	spores			10 to 50	mg/kg	qd	4	mdx1388	0.0	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.8238341968911918
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	20	80	20	mg/kg	qd	4	mdx1388	0.26666666666666666	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.8487179487179487
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	acute	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	20	80	20	mg/kg	qd	4	mdx1388	0.26666666666666666	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.8238341968911918
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	20	80	20	mg/kg	qd	4	mdx1388	0.26666666666666666	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01513239	0.8487179487179487
https://pubmed.ncbi.nlm.nih.gov/16966409	2006	sustained	n/a	goldensyrian	n/a		75	hamster		clindamycin+challenge+vancomycin	cumulativemortality	f	t	87	vpi10463	140000	cfu	spores	20	80	20	mg/kg	qd	4	mdx1388	0.26666666666666666	sustained	10	10	10	mg/kg	qd	1	antibody	mdx1388	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01241552	0.8238341968911918
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	0.8	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	12	630	225		spores	50	250	25	mg/kg	bid	5	smt19969	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	0.9	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	25	125	12.5	mg/kg	bid	5	smt19969	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	acute	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25652749	2015	sustained	spf	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	27	bi1	225		spores	50	250	25	mg/kg	bid	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	1.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	0.0	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		10	50	10	mg/kg	qd	5	smt19969	0.0	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	0.55	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	0.55	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		20	100	20	mg/kg	qd	5	smt19969	0.55	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	0.7	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	0.7	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	27	va5	894206	cfu		50	250	50	mg/kg	qd	5	smt19969	0.7	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.9	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.95	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.95	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.95	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	acute	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.8	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		10	50	10	mg/kg	qd	5	smt19969	0.8	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.9	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		20	100	20	mg/kg	qd	5	smt19969	0.9	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95	acute	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.7777777777777778
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02092935	0.8571428571428571
https://pubmed.ncbi.nlm.nih.gov/25022586	2014	sustained	n/a	goldensyrian	m		100	hamster		challenge+clindamycin	cumulativemortality	t	t	428	va11	752846	cfu		50	250	50	mg/kg	qd	5	smt19969	0.95	sustained	400	4000	200	mg	bid	10	antibiotic	smt19969	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.5
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.8
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01704937	0.6
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained	250	250	250	ml	qd	1	fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT02465463	0.75
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.847457627118644
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase2|phase3	https://ClinicalTrials.gov/show/NCT02254811	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02148601	0.9
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase1|phase2	https://ClinicalTrials.gov/show/NCT03106844	0.9183673469387755
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	acute							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.7083333333333334
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.7027027027027027
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT01398969	0.75
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	acute							fmt	cecalhomogenates	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.7
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	acute							fmt	cecalhomogenates	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.8333333333333334
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	child,adult,olderadult	phase1	https://ClinicalTrials.gov/show/NCT01914731	0.95
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	0.5
https://pubmed.ncbi.nlm.nih.gov/7309245	1981	acute	n/a	goldensyrian	m		85	hamster		vancomyin+challenge	survivors	f	p		49a	100000	cfu								cecalhomogenates	0.8	sustained							fmt	cecalhomogenates	no	therapeutic	all	child,adult	phase1	https://ClinicalTrials.gov/show/NCT02423967	1.0
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.8	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.8	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.8	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.9	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.9	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	0.9	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.6	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.6	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.6	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.45	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.45	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	0.45	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.7	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.7	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	p	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.7	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.65	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.65	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	acute	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	0.65	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	1.0	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	1.0	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		100	500	100	mg/kg	qd	5	rifaximin	1.0	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	1.0	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	1.0	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		25	125	25	mg/kg	qd	5	rifaximin	1.0	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	1.0	sustained	1200	25200	400	mg	tid	14	antibiotic	rifaximin	no	prophylactic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01670149	0.8405797101449275
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	1.0	acute	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.5726495726495726
https://pubmed.ncbi.nlm.nih.gov/18195066	2008	sustained	n/a	goldensyrian	n/a			hamster		clindamycin+challenge	cumulativemortality	t	t	87	vpi10463	100000	cfu		50	250	50	mg/kg	qd	5	rifaximin	1.0	sustained	1200	12000	400	mg	tid	10	antibiotic	rifaximin	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00269399	0.9104477611940298
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	acute	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			0.2	1	0.2	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	0.6	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			1	5	1	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t		2926	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.8947368421052632
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult	phase2	https://ClinicalTrials.gov/show/NCT01591863	0.6578947368421053
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.8365384615384616
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02179658	0.6730769230769231
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.3333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT02743234	0.5416666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT02784002	0.46153846153846156
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.7755102040816326
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child	phase3	https://ClinicalTrials.gov/show/NCT02218372	0.9342105263157895
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	16000	200	mg	qd	40	antibiotic	tiacumicinsb	no	prophylactic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT01691248	0.7109634551495017
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02437591	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8788927335640139
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00314951	0.8392156862745098
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.9166666666666666
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT01818141	0.5714285714285714
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.7142857142857143
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.8
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9375
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	100	1000	50	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	200	2000	100	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	1.0
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	yes	therapeutic	all	adult,olderadult	phase2	https://ClinicalTrials.gov/show/NCT00097422	0.9333333333333333
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8735177865612648
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	4000	200	mg	bid	10	antibiotic	tiacumicinsb	no	therapeutic	all	child,adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00468728	0.8738738738738738
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	acute	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7796610169491526
https://pubmed.ncbi.nlm.nih.gov/1929250	1991	sustained	n/a	goldensyrian	m		90	hamster		clindamycin+challenge	cumulativemortality	t	t	1	atcc9689	1000000			5	25	5	mg/kg	qd	5	tiacumicinsb	1.0	sustained	400	5600	200	mg	bid	5	antibiotic	tiacumicinsb	no	therapeutic	all	adult,olderadult	phase4	https://ClinicalTrials.gov/show/NCT02254967	0.7005649717514124
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	1.0	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	1.0	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	1.0	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	1.0	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.8	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.8	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.8	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.8	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	acute	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.9	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.9	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.9	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.9	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1000	7000	1000	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		1500	10500	1500	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.7	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	p		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.7	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.417910447761194
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00196794	0.9428571428571428
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	acute	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.462406015037594
https://pubmed.ncbi.nlm.nih.gov/11451694	2001	sustained	n/a	n/a	n/a			hamster		challenge+clindamycin	cumulativemortality	t	t		huc2-4	1000000	cfu		500	3500	500	mg/kg	qd	7	gt160-246	0.9	sustained	9	135	3	g	tid	14	antibiotic	gt160-246	no	therapeutic	all	adult,olderadult	phase3	https://ClinicalTrials.gov/show/NCT00106509	0.9658119658119658
